GILEAD SCIENCES
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, they seek to improve the care of patients suffering from life-threatening diseases. Gilead's primary areas of focus include HIV/AIDS, liver disease, and serious cardiovascular and respiratory conditions.
GILEAD SCIENCES
Industry:
Biopharma Biotechnology Health Care Manufacturing Pharmaceutical
Founded:
1987-06-22
Address:
Foster City, California, United States
Country:
United States
Website Url:
http://www.gilead.com
Total Employee:
10001+
Status:
Active
Contact:
650-574-3000
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Aerogen, Inc.
Aerogen, Inc. operates as a specialty pharmaceutical company that develops, manufactures, and commercializes pulmonary.
Apotex Inc.
APOTEX is a pharmaceutical company committed to R&D, affordable medicines to patients.
BTG Specialty Pharmaceuticals
BTG Specialty Pharmaceuticals develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings.
Charles River Laboratories International
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Eli Lilly
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients.
HyperbaricLink
HyperbaricLink is a web guide to hyperbaric oxygen therapy, an FDA-approved medical treatment for specific diseases.
IMA Group
IMA design and manufacture of automatic machines for the processing and packaging of pharmaceuticals.
Ipsen
Ipsen develops and markets medications used in oncology, neuroscience and rare diseases along with consumer healthcare products.
Johnson & Johnson
Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Libertas Pharma
Libertas Pharma a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceutical products.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Meijer
Meijer is a shopping website for grocery, health, and beauty care.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
The Stevanato Group
Stevanato Group S.p.A. manufactures packaging containers from glass tubing for the pharmaceutical industry worldwide.
Vion Pharmaceuticals Inc
Vion Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes cancer treatment technologies.
Zimmer Biomet
Zimmer Biomet designs, develops, manufactures, and markets orthopedic reconstructive and spinal products.
Current Advisors List
Advisor
Board_member
2009-07-01
Board_member
Board_member
2010-01-01
Board_member
1990-01-01
Board_member
2016-03-01
Board_member
2005-07-01
Board_member
2001-10-01
Current Employees Featured
Gary Tully Head of Legal Operations @ Gilead Sciences
Head of Legal Operations
2015-06-01
Krishnan Chellakarai Head of Information Security & Data Privacy (CISO) @ Gilead Sciences
Head of Information Security & Data Privacy (CISO)
2013-05-01
Brian Peters Senior Director, Procurement @ Gilead Sciences
Senior Director, Procurement
2017-01-01
Joel Bercu Associate Director @ Gilead Sciences
Associate Director
2015-02-01
Teresa Wang Director, Investor Relations @ Gilead Sciences
Director, Investor Relations
2021-03-01
Ahmed Afifi Vice President - Region Head Latin America @ Gilead Sciences
Vice President - Region Head Latin America
2018-10-01
Kevin Hickman Senior Manager, Supply Chain Distribution @ Gilead Sciences
Senior Manager, Supply Chain Distribution
Stacey Ma Executive Vice President, Pharmaceutical Development and Manufacturing, @ Gilead Sciences
Executive Vice President, Pharmaceutical Development and Manufacturing,
2022-06-01
Jacopo Andreose SVP Intercontinental and Global Patient Solutions @ Gilead Sciences
SVP Intercontinental and Global Patient Solutions
2021-04-01
Amadou Diagne Senior Director @ Gilead Sciences
Senior Director
2003-01-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-08-04 | MiroBio | MiroBio acquired by Gilead Sciences | 405 M USD |
| 2020-12-10 | MYR GmbH | MYR GmbH acquired by Gilead Sciences | 1.45 B EUR |
| 2020-09-13 | Immunomedics | Immunomedics acquired by Gilead Sciences | 21 B USD |
| 2020-03-02 | Forty Seven | Forty Seven acquired by Gilead Sciences | 4.9 B USD |
| 2017-12-07 | Cell Design Labs | Cell Design Labs acquired by Gilead Sciences | 567 M USD |
| 2017-08-28 | Kite Pharma | Kite Pharma acquired by Gilead Sciences | 11.9 B USD |
| 2016-04-04 | Nimbus Apollo | Nimbus Apollo acquired by Gilead Sciences | N/A |
| 2015-05-06 | Epitherapeutics | Epitherapeutics acquired by Gilead Sciences | 65 M USD |
| 2015-01-06 | Phenex Pharmaceuticals | Phenex Pharmaceuticals acquired by Gilead Sciences | 470 M USD |
| 2013-02-08 | YM BioSciences | YM BioSciences acquired by Gilead Sciences | 487.6 M USD |
Investors List
Venrock
Venrock investment in Seed Round - Gilead Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | AlloVir | Gilead Sciences investment in Post-IPO Equity - AlloVir | 126.6 M USD |
| 2022-05-23 | Exavir Therapeutics | Gilead Sciences investment in Seed Round - Exavir Therapeutics | 4 M USD |
| 2022-05-05 | Curebase | Gilead Sciences investment in Series B - Curebase | 40 M USD |
| 2022-01-26 | Kyverna Therapeutics | Gilead Sciences investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2021-12-27 | Pardes Biosciences | Gilead Sciences investment in Post-IPO Equity - Pardes Biosciences | 75 M USD |
| 2021-11-16 | Destination Tomorrow | Gilead Sciences investment in Grant - Destination Tomorrow | 1000 K USD |
| 2021-09-16 | Gritstone Bio | Gilead Sciences investment in Post-IPO Equity - Gritstone Bio | 55 M USD |
| 2021-08-11 | Tango Therapeutics | Gilead Sciences investment in Post-IPO Equity - Tango Therapeutics | 186 M USD |
| 2021-06-24 | Lyndra Therapeutics | Gilead Sciences investment in Series C - Lyndra Therapeutics | 60.5 M USD |
| 2021-03-17 | Vaccitech | Gilead Sciences investment in Series B - Vaccitech | 168 M USD |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.gilead.com Semrush global rank: 227.01 K Semrush visits lastest month: 319.31 K
- Host name: 40.70.27.35
- IP address: 40.70.27.35
- Location: Boydton United States
- Latitude: 36.6534
- Longitude: -78.375
- Metro Code: 560
- Timezone: America/New_York
- Postal: 23917
Gilead.com lookup results from whois.corporatedomains.com server:
- Domain created: 27th-May-1995
- Domain updated: 22nd-May-2024
- Domain expires: 26th-May-2025 0 Years, 53 Days left
- Website age: 29 Years, 311 Days
- Registrar Domain ID: 3896485_DOMAIN_COM-VRSN
- Registrar Url: http://cscdbs.com
- Registrar WHOIS Server: whois.corporatedomains.com
- Registrar Abuse Contact Email: domainabuse@cscglobal.com
- Registrar Abuse Contact Phone: 8887802723
- Name server:
- UDNS1.CSCDNS.NET
- UDNS2.CSCDNS.UK
More informations about "Gilead Sciences"
Gilead Sciences
Gilead Sciences, a biopharma company, achieves bold ambitions to help make the world a healthier place, leading in HIV, liver disease, cancer & inflammation.See details»
Gilead Sciences
At Gilead, we’re committed to creating possible. For more than 35 years, we’ve pursued the impossible, chased it down, tackled it for answers and surrounded it for a way in. We have worked tirelessly to bring forward medicines for life …See details»
Gilead Sciences - Wikipedia
In June 1987, Gilead Sciences was originally founded under the name Oligogen by Michael L. Riordan, a medical doctor. Riordan graduated from Washington University in St. Louis, the Johns Hopkins School of Medicine, and the Harvard Business School. The idea for Gilead began as a research project at Menlo Ventures, where Michael was an associate. Three scientific advisers worked …See details»
Meet our Leadership - Gilead Sciences
In partnership with the Board of Directors, the Gilead Leadership Team provides guidance to execute our mission and realize our vision of creating a healthier world for all people. …See details»
Canadian Leadership Team
You are now leaving www.gilead.ca and visiting our global website, Gilead.com. Please note some of the content on this site is only intended for audiences in the United States.See details»
Gilead in Canada
Gilead Sciences Canada, Inc. (Gilead Canada) is the Canadian affiliate of Gilead Sciences, Inc. and was established in Ontario, in 2006. With 21 marketed products, we work in the therapeutic areas of HIV, liver disease, oncology, …See details»
Gilead Sciences Canada - Crunchbase Company Profile & Funding
Gilead Sciences Canada operates as a subsidiary of Gilead Sciences, Inc., contributing to the global mission of transforming care for people with life-threatening illnesses. The company's …See details»
Gilead Sciences - Crunchbase Company Profile
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines in areas of unmet need. With each new discovery and experimental drug candidate, …See details»
Gilead - Devex
Gilead Sciences was founded in 1987 in Foster City, California. In 25 years, Gilead has become a lea. News. ... The Gilead Foundation, a non-profit organization established in 2005, seeks to ...See details»
Careers at Gilead Sciences
Life at Gilead. Our employees are among the most talented innovators in the biopharmaceutical industry. We work to foster an environment where our people are empowered to grow and …See details»
Gilead Sciences, Inc. - Global Health Progress
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and developed innovations in medicine for more than three decades, with the goal of creating better health …See details»
Gilead Sciences Mission, Benefits, and Work Culture - Indeed
Career development at Gilead is built on a partnership of three players: the employee, the manager and the organization. This partnership delivers on Gilead’s career promise to ensure …See details»
Mission and Core Values - Gilead
At Gilead, we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than 35 years, we’ve pursued the impossible, chased it down, tackled it …See details»
Gilead Sciences in Canada: Pioneering Canadian Innovation in ...
Jun 15, 2023 Gilead Alberta has a state-of-the-art manufacturing facility located in Edmonton that plays a pivotal role in the research, development, and production of active pharma …See details»
Gilead Sciences, Inc. - Gilead Sciences Appoints Dietmar Berger, …
Dec 12, 2024 Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a …See details»
How Gilead Is Driving Global Health Equity And Innovation - Forbes
Nov 20, 2024 Dan O’Day drives Gilead's mission to end HIV worldwide, pioneering treatments like lenacapavir and championing global health equity through bold access initiatives.See details»
Global Operations - gilead.com
This is our global website, intended for visitors seeking information on Gilead’s worldwide business. Some content on this site is not intended for people outside the United States. Visit …See details»
Careers - Gilead
Gilead is a scientific research-driven organization looking for talented individuals who are passionate about exploring the boundaries of what is possible. We are seeking people with …See details»
Gilead upgraded to Overweight from Equal Weight at Morgan …
1 day ago Morgan Stanley upgraded Gilead to Overweight from Equal Weight with a price target of $113, up from $87.The firm sees the potential for upward estimate revisions on lenacapavir …See details»
Galapagos to Spin Out Innovative Medicines, Regain Gilead Assets
2 days ago In connection with the new entity, Galapagos on Wednesday also announced that it has amended its ongoing collaboration with Gilead, signed in 2019. Galapagos will now have …See details»